Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Adc Therapeutics Sa (NY: ADCT )

3.120 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Oct 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 3.120
Bid (Size) 3.030 (2)
Ask (Size) 4.000 (1)
Prev. Close 3.120
Today's Range 3.120 - 3.120
52wk Range 0.3599 - 6.040
Shares Outstanding 76,721,543
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
From ADC Therapeutics SA
Via GlobeNewswire
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
From ADC Therapeutics SA
Via GlobeNewswire

Performance

YTD
+84.62%
+84.62%
1 Month
+14.29%
+14.29%
3 Month
-10.34%
-10.34%
6 Month
-27.61%
-27.61%
1 Year
+278.55%
+278.55%

More News

Read More
ADC Therapeutics to Present at Upcoming Investor Conferences
From ADC Therapeutics SA
Via GlobeNewswire
ADCT Stock Earnings: ADC Therapeutics Beats EPS, Misses Revenue for Q2 2024
Via InvestorPlace
ADC Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update
From ADC Therapeutics SA
Via GlobeNewswire
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
From ADC Therapeutics SA
Via GlobeNewswire
ADC Therapeutics to Host Second Quarter 2024 Financial Results Conference Call on August 6, 2024
From ADC Therapeutics SA
Via GlobeNewswire
7 Growth Stocks to Buy for Under $5 for Massive Gains
Via InvestorPlace
Intapp, ServiceNow And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
From ADC Therapeutics SA
Via GlobeNewswire
ADC Therapeutics Set to Join Russell 2000® and Russell 3000® Indexes
From ADC Therapeutics SA
Via GlobeNewswire
Stocks to Buy: 3 Biotech Bargains Delivering Breakthroughs on a Budget
Via InvestorPlace
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
From ADC Therapeutics SA
Via GlobeNewswire
ADC Therapeutics to Participate in the Jefferies Global Healthcare Conference
From ADC Therapeutics SA
Via GlobeNewswire
ADC Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
From ADC Therapeutics SA
Via GlobeNewswire
ADC Therapeutics to Participate in 2024 RBC Capital Markets Global Healthcare Conference
From ADC Therapeutics SA
Via GlobeNewswire
ADCT Stock Earnings: ADC Therapeutics Beats EPS, Misses Revenue for Q1 2024
Via InvestorPlace
BioNTech Reports Downbeat Earnings, Joins Medical Properties Trust And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
ADC Therapeutics Announces $105 Million Underwritten Offering of Common Shares and Pre-Funded Warrants
From ADC Therapeutics SA
Via GlobeNewswire
ADC Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
From ADC Therapeutics SA
Via GlobeNewswire
ADC Therapeutics Announces Initial Data from Investigator-Initiated Phase 2 Clinical Trial of ZYNLONTA® in Patients with Relapsed/Refractory Marginal Zone Lymphoma
From ADC Therapeutics SA
Via GlobeNewswire
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
From ADC Therapeutics SA
Via GlobeNewswire
ADC Therapeutics to Host First Quarter 2024 Financial Results and Pipeline Update Conference Call on May 6, 2024
From ADC Therapeutics SA
Via GlobeNewswire
Medifast Reports Mixed Results, Joins Coursera, Chegg And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
ADC Therapeutics Announces Updates on LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Glofitamab or Mosunetuzumab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
From ADC Therapeutics SA
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.